drugset / Trial / NCT00850746

A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults

NCT00850746

Phase 1 Completed 80 enrolled Astellas Pharma Inc
RandomizedCrossoverQuadruple-blind

Summary

This study evaluates whether YM443 causes any changes in the electrocardiogram of healthy adults.

Timeline

Start
2009-02
Primary completion
2009-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Acotiamide Small molecule Oral
Comparator Moxifloxacin Small molecule Oral

Indications